Trial Profile
Evaluating Pharmacokinetics and Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Single Doses of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2017
Price :
$35
*
At a glance
- Drugs Faropenem (Primary)
- Indications Bacterial infections
- Focus Pharmacodynamics
- 03 Apr 2017 Status changed from active, no longer recruiting to completed,
- 18 Mar 2017 Results published in the Journal of Antimicrobial Chemotherapy
- 20 Mar 2016 Planned End Date changed from 1 Sep 2015 to 1 Jul 2016, according to ClinicalTrials.gov record.